Three-dimensional Virtual Models' Assistance During Minimally Invasive Partial Nephrectomy Minimizes the Impairment of Kidney Function
Overview
Authors
Affiliations
Three-dimensional virtual models (3DVMs) are nowadays under scrutiny to improve partial nephrectomy (PN) outcomes. This report aims to analyze their impact on renal function preservation after minimally invasive PN. A total of 100 patients treated with minimally invasive PN with contrast-enhanced computed tomography from which a 3DVM was obtained, and having undergone baseline and 3rd month postoperative renal scans were prospectively enrolled and compared with a control group of 251 patients without 3DVMs. Weighted differential of pre- and postoperative renal scan-based effective renal plasmatic flow (b-WD ERPF) was calculated, according to the availability of 3DVMs and PADUA risk category. Multivariable logistic regression (MLR) models predicting a significant loss of renal function (LORF; ERPF drop >20%) were performed, overall and according to PADUA risk categories. The b-WD ERPF of the 3DVM group showed significantly lower LORF (-10%) than that of the control group (-19.6%, p = 0.02). In MLR, the availability of a 3DVM was found to be the only protective factor against a significant LORF (odds ratio [OR] = 0.3, p = 0.002). Moreover, after stratification as per tumor surgical complexity, this protective role was observed in both PADUA 8-9 and ≥10 category risk patients (OR = 0.3, p = 0.03 and OR = 0.1, p = 0.01). PATIENT SUMMARY: The drop in operated kidney function was significantly lower in surgeries assisted by three-dimensional virtual models (3VDMs), indicating that the availability of a 3VDM is the only protective factor against a significant functional damage.
Amparore D, Piramide F, Verri P, Checcucci E, Piana A, Basile G Eur Urol Open Sci. 2025; 74:11-20.
PMID: 40066189 PMC: 11891739. DOI: 10.1016/j.euros.2025.02.001.
Amparore D, Piramide F, Burgio M, Mandaletti M, Colombo M, Turcan A World J Urol. 2025; 43(1):126.
PMID: 39960493 DOI: 10.1007/s00345-025-05504-9.
Anwaier A, Che X, Shi L, Tian X, Ye S, Xu W J Natl Cancer Cent. 2024; 4(4):346-353.
PMID: 39735442 PMC: 11674429. DOI: 10.1016/j.jncc.2024.06.001.
Xu L, Li X, Zhang Y, Li Z, Yang K, Zhang Z World J Urol. 2024; 43(1):44.
PMID: 39714534 DOI: 10.1007/s00345-024-05395-2.
Ditonno F, Franco A, Manfredi C, Amparore D, Checcucci E, De Sio M Asian J Urol. 2024; 11(4):660-665.
PMID: 39534001 PMC: 11551323. DOI: 10.1016/j.ajur.2023.08.006.